$NEPH
NEPHROS INC Stock $neph

$neph Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222022929 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$2.409M	$2.884M	$2.187M
YoY Change	-8.65%	27.27%	-20.18%
Cost Of Revenue	$1.647M	$1.523M	$1.162M
YoY Change	34.45%	53.68%	1.04%
Gross Profit	$762.0K	$1.361M	$1.025M
YoY Change	-46.03%	6.75%	-35.53%
Gross Profit Margin	31.63%	47.19%	46.87%
Selling, General & Admin	$1.743M	$2.070M	$2.337M
YoY Change	-7.34%	11.65%	16.85%
% of Gross Profit	228.74%	152.09%	228.0%
Research & Development	$252.0K	$431.0K	$578.0K
YoY Change	-60.13%	-11.5%	3.21%
% of Gross Profit	33.07%	31.67%	56.39%
Depreciation & Amortization	$48.00K	$104.0K	$92.00K
YoY Change	-9.43%	112.24%	53.33%
% of Gross Profit	6.3%	7.64%	8.98%
Operating Expenses	$2.043M	$2.565M	$2.978M
YoY Change	-20.63%	7.23%	14.54%
Operating Profit	-$1.281M	-$1.204M	-$1.953M
YoY Change	10.24%	7.79%	93.37%
Interest Expense	$0.00	$6.000K	-$5.000K
YoY Change	-100.0%	-45.45%	-50.0%
% of Operating Profit
Other Income/Expense, Net	$31.00K	$67.00K	-$9.000K
YoY Change		-844.44%	-190.0%
Pretax Income	-$1.250M	-$1.137M	-$1.967M
YoY Change	7.57%	0.98%	264.26%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.231M	-$1.137M	-$1.967M
YoY Change	164.4%	0.98%	266.29%
Net Earnings / Revenue	-134.12%	-39.42%	-89.94%
Basic Earnings Per Share	-$0.31	-$0.12	-$0.20
Diluted Earnings Per Share	-$313.6K	-$116.8K	-$198.7K
COMMON SHARES
Basic Shares Outstanding	10.32M shares	10.30M shares	10.21M shares
Diluted Shares Outstanding	10.30M shares	10.30M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.940M	$4.179M	$5.421M
YoY Change	-46.39%	-49.52%	-33.57%
Cash & Equivalents	$3.940M	$4.179M	$5.421M
Short-Term Investments
Other Short-Term Assets	$186.0K	$151.0K	$264.0K
YoY Change	177.61%	62.37%	140.0%
Inventory	$3.488M	$4.664M	$4.679M
Prepaid Expenses
Receivables	$1.374M	$2.128M	$1.293M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.988M	$11.12M	$11.66M
YoY Change	-34.01%	-25.05%	-20.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$532.0K	$450.0K	$1.028M
YoY Change	-55.52%	-62.5%	-20.31%
Goodwill	$800.0K	$800.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$58.00K	$67.00K	$84.00K
YoY Change	-43.14%	-35.58%	-6.67%
Total Long-Term Assets	$2.217M	$3.831M	$3.871M
YoY Change	-47.2%	21.58%	18.38%
TOTAL ASSETS
Total Short-Term Assets	$8.988M	$11.12M	$11.66M
Total Long-Term Assets	$2.217M	$3.831M	$3.871M
Total Assets	$11.21M	$14.95M	$15.53M
YoY Change	-37.12%	-16.89%	-13.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$779.0K	$1.411M	$897.0K
YoY Change	21.53%	28.27%	79.4%
Accrued Expenses	$501.0K	$185.0K	$586.0K
YoY Change	-45.95%	-77.44%	-12.54%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$141.0K	$220.0K	$265.0K
YoY Change	-44.71%	-12.0%	10.42%
Total Short-Term Liabilities	$1.421M	$2.111M	$1.748M
YoY Change	-22.05%	-2.72%	23.97%
LONG-TERM LIABILITIES
Long-Term Debt	$2.000K	$11.00K	$36.00K
YoY Change	-98.91%	-95.69%	-89.09%
Other Long-Term Liabilities	$201.0K	$350.0K	$342.0K
YoY Change	-58.39%	-39.13%	-48.96%
Total Long-Term Liabilities	$203.0K	$361.0K	$378.0K
YoY Change	-69.57%	-56.51%	-62.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.421M	$2.111M	$1.748M
Total Long-Term Liabilities	$203.0K	$361.0K	$378.0K
Total Liabilities	$4.903M	$2.472M	$5.368M
YoY Change	-11.56%	-59.17%	-1.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$142.0M	-$138.8M
YoY Change
Common Stock	$10.00K	$10.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.302M	$9.221M	$10.16M
YoY Change
Total Liabilities & Shareholders Equity	$11.21M	$14.95M	$15.53M
YoY Change	-37.12%	-16.89%	-13.44%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$3.231M	-$1.137M	-$1.967M
YoY Change	164.4%	0.98%	266.29%
Depreciation, Depletion And Amortization	$48.00K	$104.0K	$92.00K
YoY Change	-9.43%	112.24%	53.33%
Cash From Operating Activities	-$170.0K	-$1.072M	-$1.797M
YoY Change	-81.32%	857.14%	2895.0%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$103.0K	-$34.00K
YoY Change	-100.0%	3333.33%	70.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	$0.00	-$103.0K	-$34.00K
YoY Change	-100.0%	3333.33%	70.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-69.00K	-67.00K	281.0K
YoY Change	-250.0%	-129.39%
NET CHANGE
Cash From Operating Activities	-170.0K	-1.072M	-1.797M
Cash From Investing Activities	0.000	-103.0K	-34.00K
Cash From Financing Activities	-69.00K	-67.00K	281.0K
Net Change In Cash	-239.0K	-1.242M	-1.550M
YoY Change	-74.19%	-1199.12%	1837.5%
FREE CASH FLOW
Cash From Operating Activities	-$170.0K	-$1.072M	-$1.797M
Capital Expenditures	$0.00	-$103.0K	-$34.00K
Free Cash Flow	-$170.0K	-$969.0K	-$1.763M
YoY Change	-81.05%	788.99%	4307.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001196298
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2021Q1	NEPH	Cashless Exercise Of Stock Options Value CashlessExerciseOfStockOptionsValue		usd
CY2021Q2	NEPH	Cashless Exercise Of Stock Options Value CashlessExerciseOfStockOptionsValue		usd
CY2021Q2	NEPH	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour		usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-32288
	dei	Entity Registrant Name EntityRegistrantName	NEPHROS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3971809
	dei	Entity Address Address Line1 EntityAddressAddressLine1	380 Lackawanna Place
	dei	Entity Address City Or Town EntityAddressCityOrTown	South Orange
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07079
	dei	City Area Code CityAreaCode	(201)
	dei	Local Phone Number LocalPhoneNumber	343-5202
	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	NEPH
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10318818	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4179000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6973000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2128000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1641000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	4664000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	4795000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	151000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	225000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	11122000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	13634000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	450000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	366000	usd
CY2022Q2	NEPH	Operating And Finance Lease Right Of Use Assets OperatingAndFinanceLeaseRightOfUseAssets	626000	usd
CY2021Q4	NEPH	Operating And Finance Lease Right Of Use Assets OperatingAndFinanceLeaseRightOfUseAssets	730000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1460000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1536000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	759000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	759000	usd
CY2022Q2	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	469000	usd
CY2021Q4	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	536000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	67000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	89000	usd
CY2022Q2	us-gaap	Assets Assets	14953000	usd
CY2021Q4	us-gaap	Assets Assets	17650000	usd
CY2022Q2	us-gaap	Secured Debt Current SecuredDebtCurrent	210000	usd
CY2021Q4	NEPH	Equipment Financing Debt Non Current EquipmentFinancingDebtNonCurrent	4000	usd
CY2022Q2	NEPH	Operating And Finance Lease Liabilities Non Current OperatingAndFinanceLeaseLiabilitiesNonCurrent	358000	usd
CY2021Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	248000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1411000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1334000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	185000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	444000	usd
CY2022Q2	NEPH	Operating And Finance Lease Liabilities Current OperatingAndFinanceLeaseLiabilitiesCurrent	305000	usd
CY2021Q4	NEPH	Operating And Finance Lease Liabilities Current OperatingAndFinanceLeaseLiabilitiesCurrent	364000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2111000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2390000	usd
CY2021Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	95000	usd
CY2022Q2	NEPH	Equipment Financing Debt Non Current EquipmentFinancingDebtNonCurrent	3000	usd
CY2021Q4	NEPH	Operating And Finance Lease Liabilities Non Current OperatingAndFinanceLeaseLiabilitiesNonCurrent	412000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	2472000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2901000	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10318818	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10318818	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10258444	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10258444	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	148040000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	147346000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	64000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138829000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-135725000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	9221000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	11695000	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	3260000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	3054000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12481000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14749000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5071000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5002000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1523000	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	991000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2685000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2140000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1361000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	1275000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14953000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17650000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2884000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2266000	usd
	us-gaap	Gross Profit GrossProfit	2386000	usd
	us-gaap	Gross Profit GrossProfit	2862000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	431000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	487000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1009000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1043000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	64000	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	51000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	116000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	101000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2070000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1854000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4418000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3853000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2565000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2392000	usd
	us-gaap	Operating Expenses OperatingExpenses	5543000	usd
	us-gaap	Operating Expenses OperatingExpenses	4997000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1204000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1117000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3157000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2135000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	6000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	11000	usd
	us-gaap	Interest Expense InterestExpense	13000	usd
	us-gaap	Interest Expense InterestExpense	24000	usd
CY2022Q2	us-gaap	Interest Income Other InterestIncomeOther	1000	usd
CY2021Q2	us-gaap	Interest Income Other InterestIncomeOther	3000	usd
	us-gaap	Interest Income Other InterestIncomeOther	3000	usd
	us-gaap	Interest Income Other InterestIncomeOther	6000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	482000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	72000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	63000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	67000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	53000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	472000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1137000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1126000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3104000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1663000	usd
CY2022Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	66000	usd
CY2021Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	60000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	129000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	119000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1203000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1186000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3233000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1782000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10299148	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9943026	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10265267	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9913196	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1137000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1126000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3104000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1663000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1137000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1124000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3107000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1667000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	66000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	60000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	129000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	119000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1203000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1184000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3236000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1786000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14749000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1967000	usd
CY2022Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	188000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3000	usd
CY2022Q1	NEPH	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	163000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2869000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	272000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13402000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1137000	usd
CY2022Q2	NEPH	Elimination Of Cumulative Translation Adjustment Upon Closing Of Wholly Owned Foreign Subsidiary EliminationOfCumulativeTranslationAdjustmentUponClosingOfWhollyOwnedForeignSubsidiary	-61000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	277000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12481000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15573000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-537000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-6000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	62000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	445000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15537000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1126000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2000	usd
CY2021Q2	NEPH	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	297000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	281000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14991000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3104000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1663000	usd
	us-gaap	Depreciation Depreciation	53000	usd
	us-gaap	Depreciation Depreciation	15000	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	143000	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	94000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	549000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	557000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	108000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	37000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	482000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	60000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	8000	usd
	NEPH	Change In Right Of Use Asset ChangeInRightOfUseAsset	174000	usd
	NEPH	Change In Right Of Use Asset ChangeInRightOfUseAsset	158000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	487000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-23000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-180000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-74000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-144000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-22000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	15000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	77000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	685000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-262000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	300000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-179000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-155000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7000	usd
	NEPH	Principal Payments On Equipment Financing PrincipalPaymentsOnEquipmentFinancing	1000	usd
	NEPH	Principal Payments On Equipment Financing PrincipalPaymentsOnEquipmentFinancing	1000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	163000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	297000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	62000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	214000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-172000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	137000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-137000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	188000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	133000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	123000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	228000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-4000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2794000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	29000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6973000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8249000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4179000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8278000	usd
	us-gaap	Interest Paid Net InterestPaidNet	13000	usd
	us-gaap	Interest Paid Net InterestPaidNet	23000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	35000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	69000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	21000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_808_eus-gaap--NatureOfOperations_zeBPG7wtGvs9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_825_zGmit9L1YNlc">Organization and Nature of Operations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nephros, Inc. (“Nephros” or the “Company”) was incorporated under the laws of the State of Delaware on April 3, 1997. The Company was founded by health professionals, scientists and engineers affiliated with Columbia University to develop advanced end stage renal disease (“ESRD”) therapy technology and products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning in 2009, Nephros introduced high performance liquid purification filters to meet the demand for water purification in certain medical markets. The Company’s filters, generally classified as ultrafilters, are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate. The Company also develops and sells water filtration products for commercial applications, focusing on the hospitality and food service markets. The water filtration business is a reportable segment, referred to as the Water Filtration segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. The pathogen detection systems business is a reportable segment, referred to as the Pathogen Detection segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2018, the Company formed a new subsidiary, Specialty Renal Products, Inc. (“SRP”), to drive the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. After SRP’s formation, the Company assigned to SRP all of the Company’s rights to three patents relating to the Company’s hemodiafiltration technology, which were carried at zero book value. SRP is a reportable segment, referred to as the Renal Products segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s primary U.S. facilities are located at 380 Lackawanna Place, South Orange, New Jersey 07079, 3221 Polaris Avenue, Las Vegas, Nevada 89102 and 1015 Telegraph Street, Unit B, Reno, Nevada 89502. These locations house the Company’s corporate headquarters, research, manufacturing, and distribution facilities. In addition, the Company maintains small administrative offices in various locations in the United States.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zIxpgfPvJWll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zitQ9DEoIWCc">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 34.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, at the date of the financial statements, and the reported amount of revenues and expenses, during the reporting period. Actual results could differ materially from those estimates. Included in these estimates are assumptions about the collection of accounts receivable, net realizable value of inventories, useful life of fixed assets and intangible assets, the assessment of expected cash flows used in evaluating goodwill and other long-lived assets, and assumptions used in determining stock compensation such as expected volatility and risk-free interest rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138800000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	142000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	142000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	142000	usd
CY2022Q2	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2021Q2	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zeCnV2rYI5c2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_z5XEOJQYb9Y6">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company deposits its cash in financial institutions. At times, such deposits may be in excess of insured limits. To date, the Company has not experienced any impairment losses on its cash. The Company also limits its credit risk with respect to accounts receivable by performing credit evaluations when deemed necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	22000	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	28000	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	8000	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	15000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	76000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3639000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3760000	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1025000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1035000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	4664000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	4795000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1688000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-228000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1460000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1688000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-152000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1536000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	38000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	38000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	76000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	76000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	152000	usd
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2022Q2	us-gaap	Goodwill Goodwill	800000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	800000	usd
CY2022Q2	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	2300000	usd
CY2021Q4	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	500000	usd
CY2022Q2	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	500000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	115000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	95000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	210000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	102000	usd
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	99000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1000	usd
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2000	usd
CY2022Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1000	usd
CY2021Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1000	usd
CY2022Q2	NEPH	Finance Lease Cost FinanceLeaseCost	2000	usd
CY2021Q2	NEPH	Finance Lease Cost FinanceLeaseCost	3000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	10000	usd
CY2021Q2	us-gaap	Variable Lease Cost VariableLeaseCost	10000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	114000	usd
CY2021Q2	us-gaap	Lease Cost LeaseCost	112000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	213000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	5000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	5000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	3000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000	usd
	NEPH	Finance Lease Cost FinanceLeaseCost	8000	usd
	NEPH	Finance Lease Cost FinanceLeaseCost	7000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	19000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	19000	usd
	us-gaap	Lease Cost LeaseCost	240000	usd
	us-gaap	Lease Cost LeaseCost	226000	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	211000	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	208000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	608000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	867000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	18000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	30000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	295000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	344000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	350000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	575000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	645000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	919000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	10000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	12000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	8000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	18000	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	18000	usd
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	30000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.080	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.080	pure
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.080	pure
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.080	pure
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	196000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	7000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	276000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	8000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	204000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	7000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	25000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	4000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	701000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	26000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	56000	usd
CY2022Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	8000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	645000	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	18000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2100000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M24D

Files In Submission

Name	View Source	Status
0001493152-22-022929-index-headers.html	Edgar Link	pending
0001493152-22-022929-index.html	Edgar Link	pending
0001493152-22-022929.txt	Edgar Link	pending
0001493152-22-022929-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
neph-20220630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
neph-20220630_cal.xml	Edgar Link	unprocessable
neph-20220630_def.xml	Edgar Link	unprocessable
neph-20220630_lab.xml	Edgar Link	unprocessable
neph-20220630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NEPH
NEPHROS INC Stock $neph

2022 Q3 Form 10-Q Financial Statement

#000149315222022929 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEPH NEPHROS INC Stock $neph

2022 Q3 Form 10-Q Financial Statement

#000149315222022929 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEPH
NEPHROS INC Stock $neph